Migraine with aura and patient foramen ovale. A different clinical entity?;Migraña con aura y foramen oval permeable. ¿Una entidad clínica diferente?

Neurologia

Volumn 23, Issue 8, 2008, Pages 503-510

  Ramirez Moreno, José María ^a   Casado Naranjo, I ^a   Gomez M ^a   Caballerro, M ^a   Serrano, A ^a   Ojalvo, M J ^a   Falcon A ^a   Tena Mora, D ^a   Calle, M ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

Aura; Migraine; Patent foramen ovale; Right to left shunting; Silent brain lesions; Stroke

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ALLERGIC ASTHMA; ANXIETY DISORDER; ARTICLE; BRAIN DAMAGE; BRAIN RIGHT TO LEFT SHUNT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EPILEPSY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PATENT FORAMEN OVALE; RAYNAUD PHENOMENON; SHUNTING; SMOKING; VERTIGO;

ADULT; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MALE; MIGRAINE WITH AURA; RISK FACTORS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; YOUNG ADULT;

EID: 55849095111     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Eng J Med 2002;346:257-70.
2. nd ed. Cephalalgia 2004;24:1-160.
3. Diener HC, Kurth T. Is migraine a risk factor for stroke? Neurology 2005;64:1496-7.
4. Kruit MC, Launer LJ, van Buchem M A, Terwindt G M, Ferrari M. Migraine as risk factor for whitte matter lesions, silent infarctions, and ischemic stroke: the evidence for a link. Headache Curr 2005;3:62-70.
5. Bousser MG, Welch KMA. Relation between migraine and stroke. Lancet Neurol 2005;4:533-42.
6. Overell JR, Bone I, Less KR. Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology 2000;55:1172-9.
7. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and rigth-to-left shunt on transcranial doppler: a case-control study. Cerebrovasc Dis 1998;8:327-30.
8. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-6.
9. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51.
10. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Intervent Cardiol 2003;16:39-42.
11. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-40.
12. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-401.
13. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-92.
14. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-5.
15. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006;37:430-4.
16. Giardini A, Donti A, Formigari R, Salomone L, Palareti G, Guidetti D, et al. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 2006;67:625-9.
17. Diener HC, on behalf of the Council of the European Headache Federation. Patent foramen ovale and migraine: no reason to intervene. J Headache Pain 2007;8:3-6.
18. Jauss M, Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000;10:490-6.
19. Piechowski-Jozwiak B, Devuyst G, Bogousslavsky J. Migraine and patent foramen ovale: a residual coincidence or a pathophysiological intrigue? Cerebrovasc Dis 2006;22:91-100.
20. Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006;26:934-9.
21. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial doppler study. Neurology 1999;52:1622-5.
22. Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005;6:328-30.
23. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-8.
24. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Eng J Med 2001;345:1740-6.
25. Pitt BR, Hammond GL, Gillis CN. Comparison of pulmonary and extrapulmonary extraction of biogenics amines. J Appl Physiol 1982;52:1545-51.
26. Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, et al. Pulmonary arteriovenous malformations. Cerebral ischemia and neurologic manifestations. Neurology 2000;55:959-64.
27. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clinical Science 2001;100:215-20.
28. Stewart WF, Shetcher A, Rasmussen BK. Migraine prevalence: a review of population-bases stdies. Neurology 1994;44:S17-23.
29. Migraine-Nimodipine European Study Group (MINES). European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Hedache 1989;29:639-42.
30. Buring JE, Peto R, Hennekens CH. Low-dose aspirin for migraine prophylaxis. JAMA 1990;264:1711-3.
31. Wilmshurst P, Nightingale S, Walsh KP, Morrison WL Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005;91:1173-5.
32. Wammes-van der Heijden EA, Smidt MH, Tijssen CC, van't Hoff AR, Lenderink AW, Egberts AC. Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks. Headache 2005;45:137-43.
33. Migraine Intervention With STARFlex Technology (MIST). Disponible en http://www.cardiosource.com/clinicaltrials/trial.asp? TriallD=1315.
34. Venketasubramanian N, Sacco RL, Di Tullio M, Sherman D, Homma S, Mohr JP. Vascular distribution of paradoxical emboli by transcranial doppler. Neurology 1993;43:1533-5.
35. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and metaanalysis of observational studies. Br Med J 2005;330:63-5.
36. Kurth T, Slomke MA, Kase CS, Cook NR, Lee I, Gaziano JM, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005;64:1020-6.
37. Swartz R, Kern R. Migraine is associated with MRI white matter abnormalities: a meta-analysis. Arch Neurol 2004;61:1366-8.
38. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34.
39. Sher Al, Terwindt G M, Picavet HSM, Verschuren WMM, Ferrari M, Launer LJ. Cardiovascular risk factor and migraine. The GEM population-based study. Neurology 2005;64:614-20.
40. Ferraris E, Marzochi N, Brovia D, Castellana CN, Pini LA. Homocysteine levels and cardiovascular disease in migraine with aura. J Headache Pain 2003;4:62-6.
41. Bousser MG. Estrogens, migraine and stroke. Stroke 2004;35: 2652-6.
42. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF. Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998;38:779-81.
43. César JM, Garcia-Avello A, Vecino AM, Sastre JL, Álvarez-Cermeño JC. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand 1995;91:412-3.
44. Hogan MJ, Brunet DG, Ford PM, Lillicrap D. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci 1988;5:420-5.
45. Tietjen GE, Al-Qasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache 2002;42:352-5.
46. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007;68:1563-70.
47. Okubo A, Miyoshi O, Baba K, Takagi M, Tsukamoto K, Kinoshita A, et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 2004;41:e97.
48. Angeli S, Carrera P, Del Seite M, Assini A, Grandis M, Biancolini D. Very high prevalence of right-to-left shunt on transcranial doppler in an Italian family with cerebral autosomal dominant angiopathy withsubcortical infarcts and leukoencephalopathy. European Neurology 2001;46:198-201.
49. Ali MM, Farooqui FA, Sohal GS. Ventrally emigrating neural tube cells contribute to the normal development of heart and great vessels. Vascul Pharmacol 2003;40:133-40.